Search – Page 54 – Indianapolis Business Journal

Home » Search

Articles

Trump makes late-term bid to lower prescription drug costs

November 20, 2020 | Associated Press

In a time of political uncertainty, it’s hard to say whether the rules will withstand expected legal challenges from the pharmaceutical industry or whether the incoming Biden administration will accept, amend or try to roll them back entirely.

After sputtering start, biosciences institute eager to innovate

November 20, 2020 | John Russell

The not-for-profit launched in 2013 as a way to bridge the gap between research universities and industry in life sciences. But its report card so far is decidedly mixed, and it just hired its third CEO.

As colleges retrench, Marian goes on offensive

November 20, 2020 | Samm Quinn

During a year filled with uncertainty for many industries, including higher education, the small Catholic university is preparing to embark on another ambitious project.

Health experts clash over use of certain drugs for COVID-19

November 20, 2020 | Associated Press

In a separate development, the FDA on Thursday gave emergency authorization to use of another anti-inflammatory drug sold by Eli Lilly, baricitinib, to be used with remdesivir.

Lilly arthritis drug gets FDA emergency use authorization for COVID-19 patients

November 19, 2020 | John Russell

The Indianapolis drugmaker said Thursday evening it was awarded an emergency use authorization for its drug baricitinib to be used in combination with Gilead Sciences’ antiviral drug remdesivir in severely ill, hospitalized patients with COVID-19.

Trump officials promise fair distribution of Lilly’s new COVID-19 antibody drug

November 11, 2020 | The Washington Post

Because of the initial limited supply, the number of doses each state receives will be determined by the number of confirmed cases and hospitalizations in a given week, federal officials said.

Lilly’s COVID-19 treatment expected to be in short supply initially

November 10, 2020 | The Washington Post

The initial scarcity of the drug and the logistical complexities of administering it could mute its immediate impact on the pandemic and raise questions about whether it is being distributed to people in the greatest need.

U.S. allows emergency use of Lilly’s COVID-19 antibody drug

November 9, 2020 | Associated Press

The Food and Drug Administration on Monday cleared the experimental drug from Indianapolis-based Eli Lilly and Co. for people 12 and older with mild or moderate COVID-19 not requiring hospitalization. It’s a one-time treatment given through an IV.

High-profile coalition is taking aim at food insecurity

November 6, 2020 | John Russell

A group of prominent corporate, not-for-profit and government organizations is launching perhaps the most ambitious food-relief and sustainability program here in years.

Lilly Endowment grants $25M to help Indiana youth groups cope with COVID

November 6, 2020 | IBJ Staff

The grants cover groups in 57 counties, with more than a third of the 297 organizations based in Indianapolis.

Indiana could get first vaccine supply by mid-November, state officials say

October 28, 2020 | John Russell

The situation remains murky, as several drugmakers and research institutions are scrambling to develop a vaccine, but none have yet won approval from the Food and Drug Administration to distribute the drug.

Lilly signs $375M deal with government for experimental COVID-19 treatment

October 28, 2020 | John Russell

Eli Lilly and Co. said Wednesday that the U.S. government will accept 300,000 vials of the drug, called bamlanivimab, if the Food and Drug Administration grants emergency authorization for its use.

2020 Women of Influence: Candy Gee

October 28, 2020 | Tom Harton

Candy Gee is responsible for advancing the Roche Diagnostics’ focus on diverse talent acquisition and development, building external partnerships, developing sustainable diversity and inclusion strategies and processes, and employee education.

2020 Women of Influence: Sarena Lin

October 28, 2020 | Tom Harton

Sarena Lin, who joined Elanco Animal Health three years ago, leads the company’s ongoing separation from former parent Eli Lilly and Co. and is simultaneously leading the integration into the company of Bayer Animal Health, which Elanco acquired this year for $7.6 billion.

« Previous 1 … 52 53 54 55 56 … 221 Next »

Search Results

4,410 results for '\"eli lilly\"'